Morphological analysis of the hippocampal region associated with an innate behaviour task in the transgenic mouse model (3xTg-AD) for Alzheimer disease

Neurologia

Volumn 28, Issue 8, 2013, Pages 497-502

  Orta Salazar, E ^a   Feria Velasco, A ^a   Medina Aguirre, G I ^b   Diaz Cintra S ^b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b CENTRO DE FÍSICA APLICADA Y TECNOLOGÍA AVANZADA   (Mexico)

Author keywords

Alzheimer disease; CA1 area; Hippocampus; Morphology; Neuron; Transgenic mouse

Indexed keywords

3XTG MOUSE; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; MORPHOMETRICS; MOUSE; NERVE CELL; NERVE CELL LESION; NONHUMAN; TASK PERFORMANCE; ÁREA CA1; ANIMAL; CA1 AREA; DRIVE; ENFERMEDAD DE ALZHEIMER; GENETICS; GENOTYPE; HIPOCAMPO; HUMAN; MORFOLOGÍA; MORPHOLOGY; NESTING; NEURONA; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; RATÓN TRANSGÉNICO; TRANSGENIC MOUSE;

ÁREA CA1; ALZHEIMER DISEASE; CA1 AREA; ENFERMEDAD DE ALZHEIMER; HIPOCAMPO; HIPPOCAMPUS; MORFOLOGÍA; MORPHOLOGY; NEURON; NEURONA; RATÓN TRANSGÉNICO; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; CA1 REGION, HIPPOCAMPAL; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; INSTINCT; MICE; MICE, TRANSGENIC; NESTING BEHAVIOR; PSYCHOMOTOR PERFORMANCE;

EID: 84885181960     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2013.01.014     Document Type: Article

References (33)

1. Thompson H. The total number of functional cells in the cerebral cortex of man, and the percentage of the total volume of the cortex composed of nerve cell bodies. J Comp Neurol 1899, 9:115-140.
2. Brody H. Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex. J Comp Neurol 1955, 102:511-556.
3. Van de Pol L., Hensel A., Barkhof F., Gertz H., Scheltens P., van der Flier W. Hippocampal atrophy in Alzheimer disease: age matters. Neurology 2006, 66:236-238.
4. Spires T., Orne J., Santa Cruz K., Pitstick R., Carlson G., Ashe K., et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol 2006, 168:1598-1607.
5. Zhang Y., Thompson R., Zhang H., Xu H. APP processing in Alzheimer's disease. Mol Brain 2011, 4:1-13.
6. Selkoe D. Alzheimer's disease: genes, proteins, and therapy. Phys Rev 2001, 81:741-766.
7. Guimerà A., Girones X., Cruz S. Actualización sobre la patología de la enfermedad de Alzheimer. Rev Esp Patol 2002, 35:21-48.
8. Mena R., Maldonado J., Luna J., García S., Trujillo S., Becerra P. Neurobiología de la enfermedad de Alzheimer. Neurobiología de los trastornos neuropsiquiátricos más prevalentes en México 2009, 121-154. Capítulo 6, México, D.F. D.G. Rosas León (Ed.).
9. Arrnold S., Hyman B., Flory J., Damasio A., Van Hoesen G. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1991, 1:103-116.
10. Hsiao A. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem 2001, 8:301-308.
11. Bories C., Guitton M., Julien C., Tremblay C., Vandal M., Msaid M., et al. Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One 2012, 7:e46111.
12. Deacon R. Burrowing in rodents: a sensitive method for detecting behavioral dysfunction. Nat Protoc 2006, 1:118-121.
13. Ahmad-Annuar A., Tabrizi S., Fisher E. Mouse models as a tool for understanding neurodegenerative diseases. Curr Opin Neurol 2003, 16:451-458.
14. Billings L., Oddo S., Green K., McGaugh J., LaFerla F. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
15. Billings L., Green K., McGaugh J., LaFerla F. Learning decreases Aβ *56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J Neurosci 2007, 27:751-776.
16. Oddo S., Caccamo A., Kitazawa M., Tseng B., LaFerla F. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003, 24:1063-1070.
17. Oddo S., Caccamo A., Shepherd J., Murphy M., Golde T., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421.
18. Oddo S., Billings L., Kesslak J., Cribbs D., LaFerla F. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004, 43:321-332.
19. Bayer T., Wirths O. Intracellular accumulation of amyloid-beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front Aging Neurosci 2010, 2:8. 10.3389/fnagi.2010.00008.
20. Deacon R. Assessing burrowing, nest construction, and hoarding in mice. J Vis Exp 2012, 59:e2607. 10.3791/2607.
21. Franklin K., Paxinos G. The mouse brain. Stereotaxic coordinates 2008, Academic Pres San Imprint Elsevier, Amsterdan. Compact 3rd ed.
22. Simic G., Kostovic I., Winblad B., Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol 1997, 379:482-494.
23. Smith R., Chung H., Rundquist S., Maat S., Colgan L., Englund E., et al. Cholinergic neuronal defect without cell loss in Huntington's disease. Hum Mol Genet 2006, 15:3119-3131.
24. Isla G., Hollister R., West H., Mui S., Growdon H., Petersen C., et al. Neuron loss correlates with but exceeds neurofibrilary tangles in Alzheimer's disease. Ann Neurol 1997, 41:17-24.
25. Takahashi R., Nam E., Edgar M., Gouras G. Alzheimer beta-amyloid peptides: normal and abnormal localization. Histol Histopathol 2002, 17:239-246.
26. Urbanc B., Cruz L., Le R., Sanders J., Ashe K., DuV K., et al. Neurotoxic eVects of thioXavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci USA 2002, 99:13990-13995.
27. Calhoun M., Wiederhold K., Abramowski D., Phinney A., Probst A., Sturchler-Pierrat C., et al. Neuron loss in APP transgenic mice. Nature 1998, 395:755-756.
28. Wirths O., Multhaup G., Bayer T. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide the first step of a fatal cascade. J Neurochem 2004, 91:513-520.
29. Parvathy S., Davies P., Haroutunian V., Purohit D.P., Davis K.L., Mohs R.C., et al. Correlation between Aβx-40-, Aβx-42-, and Aβx-43-containing amyloid plaques and cognitive. Arch Neurol 2001, 58:2025-2031.
30. Korbo L., Amrein I., Lipp H., Wolfer D., Regeur L., Oster S., et al. No evidence for loss of hippocampal neurons in non-Alzheimer dementia patients. Acta Neurol Scand 2004, 10:132-139.
31. West M., Coleman P., Flood D., Troncoso J. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994, 344:769-772.
32. West M., Kawas C., Stewart W., Rudow G., Troncoso J. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol Aging 2004, 25:1205-1212.
33. Padurarin M., Ciobica A., Mavroudis I., Fotiou D., Baloyannis S. Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients. Psychiatria Danubina 2012, 24:152-158.